Envisagenics, Inc. — Form D
Envisagenics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2017-03-03. The offering totals $2.0M. Industry: Biotechnology.
Offering
- Filed: 2017-03-03
- Form: D
- Accession: 0001144204-17-012692
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Remaining: $2.0M
- Revenue range: Decline to Disclose
- SEC file number: 021-281766
Issuer
- Name: Envisagenics, Inc.
- CIK: 0001699688
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 101 6TH AVENUE, NEW YORK, NY, 10013
- Phone: 929-777-2001
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Alan S Roemer | Director | New York, NY |
| BRADLEY S HARRIS | Executive Officer | NEW YORK, NY |
| MARTIN LUISA AKERMAN | Director | NEW YORK, NY |
| MARTIN LUISA AKERMAN | Executive Officer | NEW YORK, NY |
| MARTIN LUISA AKERMAN | Promoter | NEW YORK, NY |
| GRANT LUISA VERSTANDING | Director | BEVERLY HILLS, CA |
| MARIA LUISA PINEDA | Director | NEW YORK, NY |
| MARIA LUISA PINEDA | Executive Officer | NEW YORK, NY |
| MARIA LUISA PINEDA | Promoter | NEW YORK, NY |
Other filings by this issuer (2)
More